Related references
Note: Only part of the references are listed.Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir
Giuseppina Brancaccio et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain
Antonio Aguilera et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Epidemiology and clinical outcomes of hepatitis delta (D) virus infection in Queensland, Australia
Sarah Coghill et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2018)
Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease
Cihan Yurdaydin et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Decline and changing profile of hepatitis delta among injection drug users in Spain
Antonio Aguilera et al.
ANTIVIRAL THERAPY (2018)
Noninvasive markers for staging fibrosis in chronic delta hepatitis
V. Takyar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Antiviral Treatment and Liver- Related Complications in Hepatitis Delta
Anika Wranke et al.
HEPATOLOGY (2017)
Non-invasive fibrosis score for hepatitis delta
Gunnar L. Lutterkort et al.
LIVER INTERNATIONAL (2017)
Prevalence and epidemiology of hepatitis D among patients with chronic hepatitis B virus infection: a report from Northern Spain
Carlos Ordieres et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)
A Novel Quantitative Microarray Antibody Capture Assay Identifies an Extremely High Hepatitis Delta Virus Prevalence Among Hepatitis B Virus-Infected Mongolians
Xiaohua Chen et al.
HEPATOLOGY (2017)
Hepatitis delta-associated mortality in HIV/HBV-coinfected patients
Charles Beguelin et al.
JOURNAL OF HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Hepatitis delta infection - Current and new treatment options
Menashe Elazar et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)
The adventure of delta
Mario Rizzetto
LIVER INTERNATIONAL (2016)
Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes
Tatyana Kushner et al.
JOURNAL OF HEPATOLOGY (2015)
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
JOURNAL OF HEPATOLOGY (2015)
Hepatitis D Virus: Introduction and Epidemiology
Mario Rizzetto
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte
Katja Giersch et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2015)
Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta
Benjamin Heidrich et al.
HEPATOLOGY (2014)
Development and evaluation of a baseline-event-anticipation score for hepatitis delta
B. Calle Serrano et al.
JOURNAL OF VIRAL HEPATITIS (2014)
High Serum Levels of HDV RNA Are Predictors of Cirrhosis and Liver Cancer in Patients with Chronic Hepatitis Delta
Raffaella Romeo et al.
PLOS ONE (2014)
Hepatitis D Virus Coinfection and Superinfection
Francesco Negro
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Meta-analysis: antiviral treatment for hepatitis D
C. Triantos et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
New Enzyme-Linked Immunosorbent Assay for Detection of Antibodies against Hepatitis Delta Virus Using a Hepatitis Delta Antigen Derived from a Taiwanese Clone and Comparison to the Abbott Radioimmunoassay
Yung-Bin Kuo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study
M. Buti et al.
JOURNAL OF VIRAL HEPATITIS (2011)
A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma
Raffaella Romeo et al.
GASTROENTEROLOGY (2009)
Long-term benefit of interferon a therapy of chronic hepatitis D: Regression of advanced hepatic fibrosis
P Farci et al.
GASTROENTEROLOGY (2004)
Share Paper
